Is HSPG2 a modifier gene for Marfan syndrome?

Area of Science:

• Genetics
• Molecular Biology
• Medical Research

Background:

• Marfan syndrome (MFS) is a genetic connective tissue disorder caused by FBN1 gene variants.
• MFS exhibits significant clinical variability, suggesting the influence of modifier genes.
• Previous studies identified modifier loci for MFS manifestations in mouse models and humans.

Purpose of the Study:

• To investigate the HSPG2 gene as a candidate modifier for Marfan syndrome.
• To explore the relationship between FBN1 and HSPG2 gene expression in MFS.
• To assess the correlation between HSPG2 expression levels and MFS disease severity.

Main Methods:

• Mapping modifier loci in the mgΔloxPneo mouse model and synthenic human loci.
• Analyzing Fbn1 and Hspg2 gene expression in the spinal column and aorta of mice.
• Comparing Hspg2 expression in mice with severe versus mild MFS phenotypes.

Main Results:

• A modifier locus was identified in both MFS mouse models and human patients.
• A correlation was observed between Fbn1 and Hspg2 expression in mouse tissues.
• Mice with more severe MFS phenotypes showed lower Hspg2 expression.

Conclusions:

• HSPG2 is proposed as a strong candidate modifier gene for Marfan syndrome.
• The study suggests HSPG2 plays a role in modulating MFS disease severity.
• Further investigation of HSPG2 in MFS patients is warranted.